John Allen

John Allen is an experienced finance professional currently serving as Chief Investment Officer at Aspiriant since January 2014. Prior to this role, John held the position of Investment Advisor at GMO from March 2009 to January 2014. Earlier career milestones include Vice President roles at Andell Holdings, LLC (December 2003 - November 2008) and Stern Stewart & Co. (June 1995 - May 1999), as well as an Associate position at Donaldson, Lufkin & Jenrette (May 1999 - June 2000). John Allen earned a Bachelor of Science in Economics from the University of Virginia between 1992 and 1995.